Psychemedics Performance

The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Psychemedics are completely uncorrelated.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Psychemedics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Psychemedics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
  

Psychemedics Relative Risk vs. Return Landscape

If you would invest (100.00) in Psychemedics on November 1, 2025 and sell it today you would earn a total of  100.00  from holding Psychemedics or generate -100.0% return on investment over 90 days. Psychemedics is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of pink sheets are less volatile than Psychemedics, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

Psychemedics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Psychemedics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Psychemedics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Psychemedics is not yet fully synchronised with the market data
Psychemedics has some characteristics of a very speculative penny stock
Psychemedics has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M.
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Roughly 23.0% of the company outstanding shares are owned by corporate insiders

Psychemedics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Psychemedics Pink Sheet often depends not only on the future outlook of the current and potential Psychemedics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Psychemedics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding5.7 M
Cash And Short Term InvestmentsM

Psychemedics Fundamentals Growth

Psychemedics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Psychemedics, and Psychemedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psychemedics Pink Sheet performance.

Things to note about Psychemedics performance evaluation

Checking the ongoing alerts about Psychemedics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Psychemedics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Psychemedics is not yet fully synchronised with the market data
Psychemedics has some characteristics of a very speculative penny stock
Psychemedics has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M.
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Roughly 23.0% of the company outstanding shares are owned by corporate insiders
Evaluating Psychemedics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Psychemedics' pink sheet performance include:
  • Analyzing Psychemedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psychemedics' stock is overvalued or undervalued compared to its peers.
  • Examining Psychemedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Psychemedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psychemedics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Psychemedics' pink sheet. These opinions can provide insight into Psychemedics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Psychemedics' pink sheet performance is not an exact science, and many factors can impact Psychemedics' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Psychemedics Pink Sheet

If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk